Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The Prevention of Cardiovascular Disease in Older Adults.

Coll PP, Roche V, Olsen JS, Voit JH, Bowen E, Kumar M.

J Am Geriatr Soc. 2020 Feb 7. doi: 10.1111/jgs.16353. [Epub ahead of print] Review.

PMID:
32031247
2.

Clinical impact of a new cone beam CT angiography respiratory motion artifact reduction algorithm during hepatic intra-arterial interventions.

Dioguardi Burgio M, Benseghir T, Roche V, Garcia Alba C, Debry JB, Sibert A, Vilgrain V, Ronot M.

Eur Radiol. 2020 Jan;30(1):163-174. doi: 10.1007/s00330-019-06355-w. Epub 2019 Jul 29.

PMID:
31359127
3.

Characterization and Corrosion Resistance of Boron-Containing-Austenitic Stainless Steels Produced by Rapid Solidification Techniques.

Koga GY, Otani LB, Silva AMB, Roche V, Nogueira RP, Jorge AM Jr, Bolfarini C, Kiminami CS, Botta WJ.

Materials (Basel). 2018 Nov 5;11(11). pii: E2189. doi: 10.3390/ma11112189.

4.

Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.

Reizine E, Amaddeo G, Pigneur F, Baranes L, Legou F, Mulé S, Zegai B, Roche V, Laurent A, Rahmouni A, Calderaro J, Luciani A.

Eur Radiol. 2018 Oct;28(10):4243-4253. doi: 10.1007/s00330-018-5438-7. Epub 2018 May 2.

PMID:
29721686
5.

A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.

Kwok ZH, Roche V, Chew XH, Fadieieva A, Tay Y.

Int J Cancer. 2018 Aug 1;143(3):668-678. doi: 10.1002/ijc.31386. Epub 2018 Apr 10.

6.

Stromal miR-20a controls paracrine CXCL8 secretion in colitis and colon cancer.

Signs SA, Fisher RC, Tran U, Chakrabarti S, Sarvestani SK, Xiang S, Liska D, Roche V, Lai W, Gittleman HR, Wessely O, Huang EH.

Oncotarget. 2018 Feb 14;9(16):13048-13059. doi: 10.18632/oncotarget.24495. eCollection 2018 Feb 27.

7.

Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.

Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2017 Mar;42(3):825-832. doi: 10.1007/s00261-016-0921-6.

PMID:
27704147
8.

Students' Perception of Self-Efficacy Following Medicinal Chemistry Skills Laboratory Exercises.

Alsharif NZ, Roche VF, Qi Y.

Am J Pharm Educ. 2016 Jun 25;80(5):76. doi: 10.5688/ajpe80576.

9.
10.

Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.

Roche V, Pigneur F, Tselikas L, Roux M, Baranes L, Djabbari M, Costentin C, Calderaro J, Laurent A, Rahmouni A, Luciani A.

Eur Radiol. 2015 Jan;25(1):186-95. doi: 10.1007/s00330-014-3363-y. Epub 2014 Aug 14.

PMID:
25120205
11.

The circadian timing system in clinical oncology.

Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA.

Ann Med. 2014 Jun;46(4):191-207. doi: 10.3109/07853890.2014.916990. Review.

PMID:
24915535
12.

Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy.

Roche VP, Mohamad-Djafari A, Innominato PF, Karaboué A, Gorbach A, Lévi FA.

Chronobiol Int. 2014 Apr;31(3):409-20. doi: 10.3109/07420528.2013.864301. Epub 2014 Jan 7.

13.

Center for the Advancement of Pharmacy Education 2013 educational outcomes.

Medina MS, Plaza CM, Stowe CD, Robinson ET, DeLander G, Beck DE, Melchert RB, Supernaw RB, Roche VF, Gleason BL, Strong MN, Bain A, Meyer GE, Dong BJ, Rochon J, Johnston P.

Am J Pharm Educ. 2013 Oct 14;77(8):162. doi: 10.5688/ajpe778162.

14.

Inference on periodicity of circadian time series.

Costa MJ, Finkenstädt B, Roche V, Lévi F, Gould PD, Foreman J, Halliday K, Hall A, Rand DA.

Biostatistics. 2013 Sep;14(4):792-806. doi: 10.1093/biostatistics/kxt020. Epub 2013 Jun 6.

15.

Creation of medicinal chemistry learning communities through enhanced technology and interdisciplinary collaboration.

Henriksen B, Roche V.

Am J Pharm Educ. 2012 Oct 12;76(8):158. doi: 10.5688/ajpe768158.

16.

A collaborative and reflective academic advanced pharmacy practice experience.

Roche VF, Limpach AL.

Am J Pharm Educ. 2011 Aug 10;75(6):120. doi: 10.5688/ajpe756120.

17.

XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast.

van Dijk EL, Chen CL, d'Aubenton-Carafa Y, Gourvennec S, Kwapisz M, Roche V, Bertrand C, Silvain M, Legoix-Né P, Loeillet S, Nicolas A, Thermes C, Morillon A.

Nature. 2011 Jun 22;475(7354):114-7. doi: 10.1038/nature10118.

PMID:
21697827
19.

The hidden patient: addressing the caregiver.

Roche V.

Am J Med Sci. 2009 Mar;337(3):199-204. doi: 10.1097/MAJ.0b013e31818b114d.

PMID:
19282676
20.

Curriculum recommendations of the AACP-PSSC task force on caring for the underserved.

Zweber A, Roche VF, Assemi M, Conry JM, Shane-McWhorter L, Sorensen TD; American Association of Colleges of Pharmacy and Pharmaceutical Services Support Center Task Force.

Am J Pharm Educ. 2008 Jun 15;72(3):53.

21.

A service-learning elective in Native American culture, health and professional practice.

Roche VF, Jones RM, Hinman CE, Seoldo N.

Am J Pharm Educ. 2007 Dec 15;71(6):129.

22.
23.

The chemically elegant proton pump inhibitors.

Roche VF.

Am J Pharm Educ. 2006 Oct 15;70(5):101.

25.

Predicting which patients can resume oral nutrition after percutaneous endoscopic gastrostomy tube placement.

Naik AD, Abraham NS, Roche VM, Concato J.

Aliment Pharmacol Ther. 2005 May 1;21(9):1155-61.

26.

Ocular pharmacology of bicyclic hexahydroaporphines.

Ohia SE, Zhan GL, Leday AM, Opere CA, Kulkarni KH, Harris LC, Roche VF.

Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):87-93.

PMID:
15834461
27.

Percutaneous endoscopic gastrostomy. Clinical care of PEG tubes in older adults.

Roche V.

Geriatrics. 2003 Nov;58(11):22-6, 28-9. Review.

PMID:
14628393
28.

Southwestern Internal Medicine Conference. Etiology and management of delirium.

Roche V.

Am J Med Sci. 2003 Jan;325(1):20-30. Review.

PMID:
12544081
29.

Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines.

Saha SL, Roche VF, Pendola K, Kearley M, Lei L, Romstedt KJ, Herdman M, Shams G, Kaisare V, Feller DR.

Bioorg Med Chem. 2002 Aug;10(8):2779-93.

PMID:
12057668
30.

Assessment of the intraocular pressure-lowering activity of bicyclic derivatives of 1-substituted benzyloctahydroisoquinoline.

Saha SL, Igbo IN, Opere CA, Zhan GL, Taniyama J, Ohia SE, Roche VF.

J Ocul Pharmacol Ther. 2001 Oct;17(5):413-20.

PMID:
11765146
31.

Normal D-dimer levels in patients with pulmonary embolism.

Kutinsky I, Blakley S, Roche V.

Arch Intern Med. 1999 Jul 26;159(14):1569-72.

PMID:
10421279
32.

Long-term functional outcome after intensive care.

Roche VM, Kramer A, Hester E, Welsh CH.

J Am Geriatr Soc. 1999 Jan;47(1):18-24.

PMID:
9920225
33.

Bicyclic derivatives of hexahydroaporphine: novel agents that lower intraocular pressure.

Saha SL, Zhan G, Tang L, Opere C, Roche EB, Camras CB, Ohia SE, Roche VF.

J Ocul Pharmacol Ther. 1997 Dec;13(6):497-505.

PMID:
9436153
34.

Redesign of a hospital's internal medicine service.

Collymore VA, Roche VM, Berman D.

J Healthc Qual. 1997 Nov-Dec;19(6):28-31.

PMID:
10174390
35.

[Development of a resorbable implant: experimental reconstruction of the orbits with polylactate membranes. Animal model and preliminary results].

de Roche VR, Kuhn A, de Roche-Weber P, Printzen G, Prein J, Rahn B, Hammer B.

Handchir Mikrochir Plast Chir. 1996 Jan;28(1):28-33. German.

PMID:
8852638
36.
38.

Evaluation of potential chemoprotectants against microcystin-LR hepatotoxicity in mice.

Hermansky SJ, Stohs SJ, Eldeen ZM, Roche VF, Mereish KA.

J Appl Toxicol. 1991 Feb;11(1):65-73.

PMID:
1902496
39.

Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: relationship to trimetoquinol.

Shams G, Fedyna J, Romstedt KJ, Adejare A, Miller DD, Roche VF, Feller DR.

Gen Pharmacol. 1991;22(6):1155-63.

PMID:
1687397
40.

How 'scientific' is blood pressure measurement in leading medical journals?

Roche V, O'Malley K, O'Brien E.

J Hypertens. 1990 Dec;8(12):1167-8. No abstract available.

PMID:
1962808
41.
42.

Assessment of the in vivo and in vitro opioid activity of bridged hexahydroaporphine and isoquinoline molecules.

Roche VF, Roche EB, Lemcke PK, Wire WS, Burks TF.

J Med Chem. 1990 Jan;33(1):245-8.

PMID:
2153204
43.

[Illnesses of reflex and vagal origin].

Pelissier A, Roche V.

Chir Dent Fr. 1988 Jun 2;58(429):24-8. French. No abstract available.

PMID:
3234057
44.

Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.

Benedict MK, Roche VF, Banakar UV, Hilleman DE.

Am J Hosp Pharm. 1988 May;45(5):1117-8. No abstract available.

PMID:
3400656
45.

Visual compatibility of cibenzoline succinate with commonly used acute-care medications.

Dahl JM, Roche VF, Hilleman DE.

Am J Hosp Pharm. 1987 May;44(5):1123-5. No abstract available.

PMID:
3605123
46.

Team care for patients with chronic rheumatic disease.

Gross M, Brandt KD, Feinberg J, Korba E, Rankin M, Roche V.

J Allied Health. 1982 Nov;11(4):239-47.

PMID:
6984443
47.

Differenzierung von Geweben und ganzen Organen in Transplantaten der bastardmerogonischen Kombination Triton alpestris (♀) × Triton palmatus ♂.

de Roche V.

Wilhelm Roux Arch Entwickl Mech Org. 1937 Dec;135(4):620-663. doi: 10.1007/BF00596214. German. No abstract available.

PMID:
28354471

Supplemental Content

Support Center